default author photo

Conall H. Watson

UK Health Security Agency

London

United Kingdom

  • UK Health Security Agency

SCHOLARLY PAPERS

2

DOWNLOADS

251

TOTAL CITATIONS

1

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Protecting Infants Against RSV Disease: An Impact and Cost-Effectiveness Comparison of Long-Acting Monoclonal Antibodies and Maternal Vaccination

Number of pages: 28 Posted: 05 Sep 2023
David Hodgson, Edwin van Leeuwen, Neil Wilkins, Conall H. Watson, Jonathan Crofts, Stefan Flasche, Mark Jit and Katherine E. Atkins
London School of Hygiene & Tropical Medicine - Centre for Mathematical Modelling of Infectious Diseases, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency, London School of Hygiene & Tropical Medicine, New York University (NYU) and London School of Hygiene & Tropical Medicine
Downloads 149 (497,070)
Citation 1

Abstract:

Loading...

RSV, cost-effectiveness analysis, mathematical modelling, maternal vaccination, monoclonal antibodies

2.

Rvsv-Zebov Vaccination in People with Pre-Existing Immunity to Ebolavirus: An Open-Label Safety and Immunogenicity Study in Guinean Communities Affected by Ebola Virus Disease (L’Essai Proches)

Number of pages: 18 Posted: 09 May 2024
Conall H. Watson, Pierre-Stéphane Gsell, Yper Hall, Anton Camacho, Ximena Riveros, Godwin Enwere, Andrea Vicari, Séverine Danmadji Nadlaou, Alhassane Toure, Ismaila M. Sani, Abdourahamane Diallo, Aboubacar Barry, Cece Kolie, Sophie Duraffour, Andre Maomou, Kassie Dore, Honora A. Djidonou, Aminata Bagayoko, Philos P. Damey, Mabetty Camara, Fatoumata Battouly Diallo, Thierno Oumar Fofana, Kalidou Toure, Mohamed Diaby, Lansana Sylla, Doussou Conde, Ibrahima Lansana Kaba, Tom Tipton, Rosalind M. Eggo, Michael Marks, Chrissy H. Roberts, Thomas Strecker, Stephan Günther, Sakoba Keita, W. John Edmunds, Miles W. Carroll and Ana Maria Henao Restrepo
UK Health Security Agency, World Health Organization (WHO), UK Health Security Agency, Epicentre (Paris), World Health Organization (WHO), World Health Organization (WHO), Pan American Health Organization, World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), Bernhard-Nocht-Institute for Tropical Medicine (BNITM), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), Gamal Abdel Nasser University, World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), University of Oxford - Pandemic Sciences Institute, London School of Hygiene & Tropical Medicine - Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine - Department of Clinical Research, London School of Hygiene & Tropical Medicine, University of Marburg, Bernhard-Nocht-Institute for Tropical Medicine (BNITM), World Health Organization (WHO), London School of Hygiene & Tropical Medicine, University of Oxford - Wellcome Trust Centre for Human Genetics and Independent
Downloads 102 (679,608)

Abstract:

Loading...

Ebola virus disease, Ebola, vaccine, rVSV-ZEBOV, safety, immunogenicity, cohort study